David E. Geller
Nemours Children's Clinic
Orlando
FL 32801
USA
Name/email consistency: high
- Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa. Geller, D.E., Flume, P.A., Staab, D., Fischer, R., Loutit, J.S., Conrad, D.J. Am. J. Respir. Crit. Care Med. (2011)
- Respiratory care and cystic fibrosis. Geller, D.E., Rubin, B.K. Respir. Care (2009)
- Aerosol antibiotics in cystic fibrosis. Geller, D.E. Respir. Care (2009)
- Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety. Geller, D.E., Konstan, M.W., Smith, J., Noonberg, S.B., Conrad, C. Pediatr. Pulmonol. (2007)
- Clinical side effects during aerosol therapy: cutaneous and ocular effects. Geller, D.E. J. Aerosol. Med (2007)
- Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler. Geller, D.E. Respir. Care (2005)
- Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system. Geller, D.E., Rosenfeld, M., Waltz, D.A., Wilmott, R.W. Chest (2003)
- Bolus inhalation of rhDNase with the AERx system in subjects with cystic fibrosis. Geller, D., Thipphawong, J., Otulana, B., Caplan, D., Ericson, D., Milgram, L., Okikawa, J., Quan, J., Bowman, C.M. J. Aerosol. Med (2003)
- Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis. Geller, D.E., Pitlick, W.H., Nardella, P.A., Tracewell, W.G., Ramsey, B.W. Chest (2002)
- New liquid aerosol generation devices: systems that force pressurized liquids through nozzles. Geller, D.E. Respir. Care (2002)
